J2865 HCPCS code: Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
J2865 is the HCPCS Level II code for injection, sulfamethoxazole 5 mg and trimethoprim 1 mg. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 3000 per day on DME suppliers.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2025-04-01 |
| Last action effective | 2025-04-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 3000 | Prescribing Information |
| outpatient hospital claims | 3000 | Prescribing Information |
| practitioner claims | 3000 | Prescribing Information |
What changed for J2865
- April 2025: Code appears in this HCPCS release
- 2025-04-01: J2865 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2865?
J2865 is the HCPCS Level II code for injection, sulfamethoxazole 5 mg and trimethoprim 1 mg. Short descriptor: "Inj sulfameth/trim 5 mg/1 mg".
Does Medicare cover J2865?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J2865 can be billed per day?
3000 on DME suppliers; 3000 on outpatient hospital claims; 3000 on practitioner claims (NCCI medically unlikely edits).
Related J28 codes
- J2800 — Injection, methocarbamol, up to 10 ml
- J2801 — Injection, risperidone (rykindo), 0.5 mg
- J2802 — Injection, romiplostim, 1 microgram
- J2804 — Injection, rifampin, 1 mg
- J2805 — Injection, sincalide, 5 micrograms
- J2806 — Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
- J2810 — Injection, theophylline, per 40 mg
- J2820 — Injection, sargramostim (gm-csf), 50 mcg
- J2840 — Injection, sebelipase alfa, 1 mg
- J2850 — Injection, secretin, synthetic, human, 1 microgram
- J2860 — Injection, siltuximab, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2865
- Watch J2865 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2865
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.